17beta-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta.
The aim of the present study was to investigate anti-proliferative and anti-atherogenic properties of 17beta-estradiol in balloon injured female and male rabbit aortae. Thirty-two female and 32 male New Zealand White rabbits where gonadectomised. Vascular injury was performed with a balloon catheter in the lower abdominal aorta. Male and female rabbits were randomised into four groups of eight animals each. Only two of four groups received a 0.5% cholesterol-enriched diet. One cholesterol-diet group and one normal-diet group received intramuscular injections of estradiol valerate (1 mg/kg body weight/week). After 28 days, the denuded part of the abdominal aorta was excised and analysed by morphometry and immunohistochemistry. Estrogen treatment did not show an inhibitory effect on neointimal proliferation in normo-cholesterolemic male or female rabbits. A gender independent inhibitory effect of 17beta-estradiol was seen on atheroma development in cholesterol-fed female and male rabbits, while plasma total cholesterol levels were significantly reduced in male rabbits only. The 17beta-estradiol treatment was associated with a significantly decreased number of luminal endothelial cells in normo and hyper-cholesterolemic female rabbits, as evaluated by immunohistochemical staining for 'von Willebrand factor'. Staining for Ki-67-positive proliferating cells after 28 days showed a statistically significant increased proliferative activity in the neointima of hyper-cholesterolemic female rabbits. The neointimal content of macrophages increased significantly in all hyper-cholesterolemic rabbits. Under 17beta-estradiol treatment, the number of macrophages was increased in female and decreased in male rabbits by tendency. Additionally, the 'classical' vascular estrogen receptor was present in both female and male rabbit aortae without statistically significant differences. In conclusion, 17beta-estradiol did not reduce post-injury neointima formation in normo-cholesterolemic rabbits. However, in hyper-cholesterolemic rabbits, 17beta-estradiol reduced atheroma development gender independently. This effect cannot be explained by lowering of plasma cholesterol levels or endothelium-mediated pathways, and requires further investigation on, for example, antioxidative, antiproliferative or estrogen receptor mediated effects.
Finking
G
G
Department of Internal Medicine, Cardiology, University of Ulm, Robert-Koch-Strasse 8, 89081, Ulm, Germany. gerald.finking@medizin.uni-ulm.de
Krauss
N
N
Römer
S
S
Eckert
S
S
Lenz
C
C
Kamenz
J
J
Menke
A
A
Brehme
U
U
Hombach
V
V
Hanke
H
H
D000199:Actins / Q000378:metabolism; D000818:Animals; D001011:Aorta / Q000293:injuries*; D001161:Arteriosclerosis / Q000517:prevention & control*; D002404:Catheterization / Q000009:adverse effects*; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004730:Endothelium, Vascular / Q000473:pathology; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D008264:Macrophages / Q000473:pathology; D008297:Male; D011817:Rabbits; D011960:Receptors, Estrogen / Q000378:metabolism; D017539:Tunica Intima / Q000473:pathology*; D014947:Wounds and Injuries / Q000473:pathology*
D000199:Actins; D011960:Receptors, Estrogen; D004958:Estradiol; D002784:Cholesterol